查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386417

创伤后压力症候群 (PTSD) 市场报告：2030 年趋势、预测与竞争分析

Post-Traumatic Stress Disorder (PTSD) Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

创伤后压力症候群（PTSD）的趋势和预测

预计到 2030 年，全球创伤后压力症候群 (PTSD) 市场将达到约 14 亿美元，2024 年至 2030 年年复合成长率为 4.6%。这个市场的主要驱动因素是创伤后压力症候群的盛行率不断上升、人们对心理健康问题的认识不断增强，以及由于创伤后压力症候群治疗的研发活动激增而对心理健康服务的需求不断增加混乱，需求不断增加。由于医院和诊所市场的机会，全球创伤后压力症候群（PTSD）市场的未来性广阔。

创伤后压力症候群 (PTSD) 市场洞察

Lucintel 预测，由于该年龄层患者数量众多、成年人口中精神疾病盛行率不断上升以及创伤经历增加，因此在预测期内，成年人口将继续占据市场的很大一部分。

在这个市场中，医院可能仍占较大份额，因为它们在初级卫生保健机构中诊断和治疗创伤后压力症候群病例方面的重要性，以及管理急性危机的能力。

由于创伤后压力症候群的盛行率不断上升以及对精神卫生保健服务的需求不断增加，北美将继续成为最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球创伤后压力症候群（PTSD）市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球创伤后压力症候群（PTSD）市场趋势（2018-2023）与预测（2024-2030）
  • 按产品类型分類的全球创伤后压力症候群 (PTSD) 市场
    • 抗忧郁症
    • 认知疗法
    • 抗焦虑药
    • 暴露疗法
    • 眼动减敏与再处理（EMDR）
    • 治疗方法PSTD
  • 按年龄分類的全球创伤后压力症候群 (PTSD) 市场
    • 孩子
    • 成人
  • 全球创伤后压力症候群 (PTSD) 市场（按最终用途）
    • 医院
    • 诊所

第4章2018-2030年分地区市场趋势及预测分析

  • 全球创伤后压力症候群 (PTSD) 市场（按地区）
  • 北美创伤后压力症候群（PTSD）市场
  • 欧洲创伤后压力症候群（PTSD）市场
  • 亚太地区创伤后压力症候群（PTSD）市场
  • 其他区域创伤后压力症候群 (PTSD) 市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球创伤后压力症候群 (PTSD) 市场成长机会
    • 按年龄分類的全球创伤后压力症候群 (PTSD) 市场成长机会
    • 全球创伤后压力症候群 (PTSD) 市场成长机会（按最终用途）
    • 全球创伤后压力症候群 (PTSD) 市场成长机会（按地区）
  • 全球创伤后压力症候群（PTSD）市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球创伤后压力症候群 (PTSD) 市场容量扩张
    • 全球创伤后压力症候群 (PTSD) 市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly & Company
  • Azevan Pharmaceuticals
  • Otsuka Pharmaceutical
  • AstraZeneca
  • Neurocrine Biosciences
  • Nuvo Pharmaceuticals
  • Marinus Pharmaceuticals
  • Tonix Pharmaceuticals
简介目录

Post-Traumatic Stress Disorder (PTSD) Trends and Forecast

The future of the global post-traumatic stress disorder (PTSD) market looks promising with opportunities in the hospital and clinic markets. The global post-traumatic stress disorder (PTSD) market is expected to reach an estimated $1.4 billion by 2030 with a CAGR of 4.6% from 2024 to 2030. The major drivers for this market are increasing prevalence of post-traumatic stress disorders, rising awareness towards mental health issues, and growing demand of mental health services along with surhing R&D activities for treatment of post-traumatic stress disorders.

A more than 150-page report is developed to help in your business decisions.

Post-Traumatic Stress Disorder (PTSD) by Segment

The study includes a forecast for the global post-traumatic stress disorder (PTSD) by product type, age group, end use, and region.

Post-Traumatic Stress Disorder (PTSD) Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Antidepressants
  • Cognitive Therapy
  • Anti-Anxiety Drugs
  • Exposure Therapy
  • Eye Movement Desensitization & Reprocessing (EMDR)
  • PSTD Therapeutics

Post-Traumatic Stress Disorder (PTSD) Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

  • Children
  • Adult

Post-Traumatic Stress Disorder (PTSD) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics

Post-Traumatic Stress Disorder (PTSD) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Post-Traumatic Stress Disorder (PTSD) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies post-traumatic stress disorder (PTSD) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the post-traumatic stress disorder (PTSD) companies profiled in this report include-

  • Glaxosmithkline
  • Pfizer
  • Eli Lilly & Company
  • Azevan Pharmaceuticals
  • Otsuka Pharmaceutical
  • Astrazeneca
  • Neurocrine Biosciences
  • Nuvo Pharmaceuticals
  • Marinus Pharmaceuticals
  • Tonix Pharmaceuticals

Post-Traumatic Stress Disorder (PTSD) Market Insights

Lucintel forecasts that adult will remain the larger semgent over the forecast period due to large number of patients in this age group, growing mental health disorder cases in the adult group, and rising traumatic experiences.

Within this market, hospitals will remain the larger segment due to their importance in primary healthcare settings for the diagnosis and treatment of post-traumatic stress disorder cases along with their capabilities to manage acute crisis.

North America will remain the largest region due to increasing prevalence of post-traumatic stress disorder and growing demand of mental healthcare services in the region.

Features of the Global Post-Traumatic Stress Disorder (PTSD) Market

Market Size Estimates: Post-traumatic stress disorder (PTSD) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Post-traumatic stress disorder (PTSD) market size by product type, age group, end use, and region in terms of value ($B).

Regional Analysis: Post-traumatic stress disorder (PTSD) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, age groups, end uses, and regions for the post-traumatic stress disorder (PTSD) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the post-traumatic stress disorder (PTSD) market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the post-traumatic stress disorder (PTSD) market size?

Answer: The global post-traumatic stress disorder (PTSD) market is expected to reach an estimated $1.4 billion by 2030.

Q.2 What is the growth forecast for post-traumatic stress disorder (PTSD) market?

Answer: The global post-traumatic stress disorder (PTSD) market is expected to grow with a CAGR of 4.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the post-traumatic stress disorder (PTSD) market?

Answer: The major drivers for this market are increasing prevalence of post-traumatic stress disorders, rising awareness towards mental health issues, and growing demand of mental health services along with surhing R&D activities for treatment of post-traumatic stress disorders.

Q4. What are the major segments for post-traumatic stress disorder (PTSD) market?

Answer: The future of the post-traumatic stress disorder (PTSD) market looks promising with opportunities in the hospital and clinic markets.

Q5. Who are the key post-traumatic stress disorder (PTSD) market companies?

Answer: Some of the key post-traumatic stress disorder (PTSD) companies are as follows:

  • Glaxosmithkline
  • Pfizer
  • Eli Lilly & Company
  • Azevan Pharmaceuticals
  • Otsuka Pharmaceutical
  • Astrazeneca
  • Neurocrine Biosciences
  • Nuvo Pharmaceuticals
  • Marinus Pharmaceuticals
  • Tonix Pharmaceuticals

Q6. Which post-traumatic stress disorder (PTSD) market segment will be the largest in future?

Answer: Lucintel forecasts that adult will remain the larger semgent over the forecast period due to large number of patients in this age group, growing mental health disorder cases in the adult group, and rising traumatic experiences.

Q7. In post-traumatic stress disorder (PTSD) market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to increasing prevalence of post-traumatic stress disorder and growing demand of mental healthcare services in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the post-traumatic stress disorder (PTSD) market by product type (antidepressants, cognitive therapy, anti-anxiety drugs, exposure therapy, eye movement desensitization & reprocessing (EMDR), and PSTD therapeutics), age group (children and adult), end use (hospitals and clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Post-Traumatic Stress Disorder (PTSD) Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Post-Traumatic Stress Disorder (PTSD) Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Post-Traumatic Stress Disorder (PTSD) Market by Product Type
    • 3.3.1: Antidepressants
    • 3.3.2: Cognitive Therapy
    • 3.3.3: Anti-Anxiety Drugs
    • 3.3.4: Exposure Therapy
    • 3.3.5: Eye Movement Desensitization & Reprocessing (EMDR)
    • 3.3.6: PSTD therapeutics
  • 3.4: Global Post-Traumatic Stress Disorder (PTSD) Market by Age Group
    • 3.4.1: Children
    • 3.4.2: Adult
  • 3.5: Global Post-Traumatic Stress Disorder (PTSD) Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Clinics

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Post-Traumatic Stress Disorder (PTSD) Market by Region
  • 4.2: North American Post-Traumatic Stress Disorder (PTSD) Market
    • 4.2.1: North American Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
    • 4.2.2: North American Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics
  • 4.3: European Post-Traumatic Stress Disorder (PTSD) Market
    • 4.3.1: European Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
    • 4.3.2: European Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics
  • 4.4: APAC Post-Traumatic Stress Disorder (PTSD) Market
    • 4.4.1: APAC Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
    • 4.4.2: APAC Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics
  • 4.5: ROW Post-Traumatic Stress Disorder (PTSD) Market
    • 4.5.1: ROW Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
    • 4.5.2: ROW Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by Age Group
    • 6.1.3: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by End Use
    • 6.1.4: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by Region
  • 6.2: Emerging Trends in the Global Post-Traumatic Stress Disorder (PTSD) Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Post-Traumatic Stress Disorder (PTSD) Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Post-Traumatic Stress Disorder (PTSD) Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GlaxoSmithKline
  • 7.2: Pfizer
  • 7.3: Eli Lilly & Company
  • 7.4: Azevan Pharmaceuticals
  • 7.5: Otsuka Pharmaceutical
  • 7.6: AstraZeneca
  • 7.7: Neurocrine Biosciences
  • 7.8: Nuvo Pharmaceuticals
  • 7.9: Marinus Pharmaceuticals
  • 7.10: Tonix Pharmaceuticals